通过组合代谢工程在大肠杆菌中高效生产瓜诺辛
Kun Zhang1, Mengxing Qin1, Yu Hou1
1Henan Province Engineering Laboratory for Bioconversion Technology of Functional Microbes, College of Life Sciences, Henan Normal University, Xinxiang, 453007, China.
Microbial cell factories
|June 19, 2024
概括
大肠杆菌的代谢工程显著增强了瓜诺辛的生产. 这项研究优化了精氨酸合成途径和发酵条件,实现了工业应用的高关酸标位.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 微生物发酵 微生物发酵
背景情况:
- 关诺辛是一种重要的纯氨酸核oside,用于食品添加剂和制药.
- 微生物发酵是瓜诺辛生产的主要方法.
- 由于复杂的代谢途径和调节,现有的瓜诺辛生产菌株存在局限性,阻碍了工业应用.
研究的目的:
- 通过系统的代谢工程来增强大肠杆菌中瓜诺辛的产生.
- 为了克服当前瓜诺辛产生微生物菌株的局限性.
- 为了实现高效和工业相关的瓜诺辛产量.
主要方法:
- 来自Bacillus subtilis和prs基因的 purin合成途径的过度表达.
- 删除瓜诺辛代谢基因和减弱purA表达以消除反抑制.
- 糖解和Entner-Doudoroff (ED) 途径的修改,包括还氧化辅因子再平衡.
- 传送器工程和加强瓜诺辛合成途径.
主要成果:
- 工程化大肠杆菌通过代谢途径优化实现了134.9 mg/L的瓜诺辛标位.
- 在72小时的料批发发酵过程中,最终的瓜诺辛度为289.8 mg/L.
- 该研究表明,瓜诺辛积累的显著改善.
结论:
- 组合代谢工程成功优化了瓜诺辛合成途径.
- 开发的代谢工程策略可能适用于其他核oside产品的高效合成.
- 这项研究为改善工业规模核酸生产提供了基础.
相关概念视频
Stringent Response in E. coli
528
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
528
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94


